• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Study: Retina Implant’s chip restores vision in blind patients

Study: Retina Implant’s chip restores vision in blind patients

June 1, 2015 By Brad Perriello

retina-implant-1x1

Retina Implant AG, which is developing subretinal implants for patients blinded by retinitis pigmentosa, said a new study published in Vision Research shows positive results in patients treated with its Alpha IMS subretinal microchip.

More than 86% of patients implanted with the device experienced improved ability to detect light and identify specific light sources, the study showed. More than 50% of the 29 blind patients reported restoration of “useful visual experiences in daily life, including the recognition of shapes and household objects, improved ability to identify facial features” and some ability to read letters, the Reutlingen, Germany-based company said.

“The publication of this data is the culmination of the hard work and dedication of some of the world’s leading retinal specialists collaborating to provide life-changing technology to those in need. The impact of RP is profound for patients, and with no treatment options available until recently, diagnosing patients with the disease has been extremely difficult. For years, the ophthalmology community has strived to develop a treatment or technology that offers a solution to help RP patients regain some useful vision. It is incredibly gratifying to have reached this point,” study lead author Dr. Katarina Stingl of the University of Tuebingen, Germany, said in a prepared statement.

The restored vision was described as “rudimentary” in the study, but potentially useful in previously blind patients. Nearly 50% could recognize object shapes, and almost 66% could localize high-contrast objects. The study added a caveat, stating that “it cannot be predicted at present, which patients after implantation may have very useful object perception in daily life and which patients may have only improved light perception and how long the restoration of very-low-vision abilities will be maintained.”

“Retina Implant’s mission is to provide all late-stage RP patients with a safe, effective device to restore some of the vision they have lost. Through the establishment of new clinical partners across Europe, securing reimbursement in those countries as well as launching a clinical trial in the U.S., we are executing on our mission to increase access to our technology worldwide,” CEO Walter-G Wrobel said in a press release.

Retina Implant AG won CE Mark approval in the European Union for the device in 2013, and won reimbursement from Germany’s government health system for the device in 2014.

Filed Under: Business/Financial News, Optical/Ophthalmic Tagged With: Clinical Trials, Retina Implant AG

More recent news

  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment
  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit
  • Medtronic issues safety notice for Hugo surgical robot console in Europe

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy